Investigation of Urine Organic Acid Profile in Coronavirus Disease (COVID-19) Patients


KAZEZOĞLU C., İRVEM A., Sutaşir Y. T., Kirgiz B., Çakiroğlu B., YILMAZ H., ...Daha Fazla

Clinical Laboratory, cilt.70, sa.10, ss.1863-1872, 2024 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 70 Sayı: 10
  • Basım Tarihi: 2024
  • Doi Numarası: 10.7754/clin.lab.2024.240319
  • Dergi Adı: Clinical Laboratory
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1863-1872
  • Anahtar Kelimeler: COVID-19, SARS-CoV-2, urine organic acid
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Backgrounds: Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The high mortality and morbidity rate and its course with a wide variety of clinical symptoms indicate that the disease affects many metabolic pathways. The aim of our study was to investigate the metabolic effects of SARS-CoV-2 by evaluating the urinary organic acid profile in patients with SARSCoV-2 infection. Can metabolites in urine guide the diagnosis, follow-up, treatment, and prognosis of COVID-19? Methods: Forty-two patients, including 30 SARS-CoV-2 RT-PCR positive patients and 12 SARS-CoV-2 RT-PCR negative controls, were studied. SARS-COV-2 RT-PCR of nasopharyngeal swab samples was studied. Urines were evaluated in the GCMS-QP2010 SE Gas Chromatograph Mass Spectrometer (SHIMADZU) device for organic acid profile in the metabolism laboratory. Urine organic acid profile was evaluated by studying 117 organic acids in each patient. Results: Tiglylglycine, 2-hydroxybutyric acid, 4-hydroxyphenylpyruvic acid, 3-hydroxypropionic acid, erythro-4,5-dihydroxyhexanoic acid lactone, 2-hydroxyphenylacetic acid, N-acetyltyrosine, 3-phenyllactic acid, 5-hydroxy-indolacetic acid, 3-hydroxysebacic acid, palmitic acid, 3-methylglutaconic acid, 3-methylglutaric acid, lactic acid, pyruvic acid-oxime, 3-hydroxysobutyric acid, and organic acids were found to be increased, compared to the control group. Conclusions: Tiglylglycine has been specifically identified as a potential biomarker of respiratory chain disorders. The deterioration in lipid metabolism and pyruvate pathway in COVID-19 patients was evaluated as remarkable.